Association Between Expression of Immune Response-Related Genes and Response to Nivolumab in Metastatic Non-Small Cell Lung Cancer

被引：0
|
作者：
Obuti Saito, A. [1 ]
Araujo, D. [2 ]
Sousa Filho, C. [1 ]
Sa, D. [1 ]
Walter, L. [3 ]
Silva, A. P. [3 ]
Berra, C. [4 ]
Germano, J. [5 ]
Pinto, C. [6 ]
Carraro, D. M. [4 ]
De Lima, V. C. [1 ]
机构：
[1] AC Camargo Canc Ctr, Med Oncol, Sao Paulo, Brazil
[2] Hosp Base, Sao Jose Do Rio Preto, Brazil
[3] AC Camargo Canc Ctr, Biobank, Sao Paulo, Brazil
[4] AC Camargo Canc Ctr, Int Res Ctr, Genom & Mol Biol Grp, Sao Paulo, Brazil
[5] AC Camargo Canc Ctr, Stat, Sao Paulo, Brazil
[6] AC Camargo Canc Ctr, Pathol, Sao Paulo, Brazil
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
Nivolumab; gene expression profile; non-small-cell lung carcinoma;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P33.19
引用
收藏
页码：S413 / S413
页数：1
相关论文
共 50 条
  • [1] The immune response-related mutational signatures and driver genes in non-small-cell lung cancer
    Chen, Hao
    Chong, Wei
    Teng, Changcai
    Yao, Yueliang
    Wang, Xin
    Li, Xue
    CANCER SCIENCE, 2019, 110 (08) : 2348 - 2356
  • [2] Mutation and expression of multiple treatment response-related genes in a population with locally advanced non-small cell lung cancer
    Lu, Hong-Yang
    Su, Dan
    Pan, Xiao-Dan
    Jiang, Hong
    Ma, Sheng-Lin
    ONCOLOGY LETTERS, 2012, 3 (02) : 415 - 420
  • [3] Durable complete response to nivolumab in a patient with HIV and metastatic non-small cell lung cancer
    McCullar, Brennan
    Alloway, Taylor
    Martin, Michael
    JOURNAL OF THORACIC DISEASE, 2017, 9 (06) : E540 - E542
  • [4] Association between immune-related adverse events and efficacy of nivolumab in advanced non-small cell lung cancer
    Usui, Yuko
    Udagawa, Hibiki
    Kirita, Keisuke
    Umemura, Shigeki
    Matsumoto, Shingo
    Yoh, Kiyotaka
    Niho, Seiji
    Goto, Koichi
    ANNALS OF ONCOLOGY, 2017, 28
  • [5] Association between lung microbiome and immune checkpoint blockade response in non-small cell lung cancer patients
    Kim, Joon
    Yong, Seung-Hyun
    Kim, Eun Young
    Oh, Chang-Myung
    Lee, Sang Hoon
    RESPIROLOGY, 2024, 29 : 52 - 52
  • [6] Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non-Small Cell Lung Cancer
    Haratani, Koji
    Hayashi, Hidetoshi
    Chiba, Yasutaka
    Kudo, Keita
    Yonesaka, Kimio
    Kato, Ryoji
    Kaneda, Hiroyasu
    Hasegawa, Yoshikazu
    Tanaka, Kaoru
    Takeda, Masayuki
    Nakagawa, Kazuhiko
    JAMA ONCOLOGY, 2018, 4 (03) : 374 - 378
  • [7] Immune Thrombocytopenia Induced by Nivolumab in a Metastatic Non-Small Cell Lung Cancer Patient
    Karakas, Yusuf
    Yuce, Deniz
    Kilickap, Saadettin
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (10) : 621 - +
  • [8] Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer
    Ottonello, Selene
    Genova, Carlo
    Cossu, Irene
    Fontana, Vincenzo
    Rijavec, Erika
    Rossi, Giovanni
    Biello, Federica
    Dal Bello, Maria Giovanna
    Tagliamento, Marco
    Alama, Angela
    Coco, Simona
    Boccardo, Simona
    Vanni, Irene
    Ferlazzo, Guido
    Moretta, Lorenzo
    Grossi, Francesco
    Mingari, Maria Cristina
    Carrega, Paolo
    Pietra, Gabriella
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [9] Lung Tissue Injury as an Atypical Response to Nivolumab in Non-Small Cell Lung Cancer
    Rampinelli, Cristiano
    Spitaleri, Gianluca
    Passaro, Antonio
    Pochesci, Alessia
    Ancona, Eleonora
    De Marinis, Filippo
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 196 (10) : 1349 - 1350
  • [10] Patterns of Response to Nivolumab in Patients with Non-Small Cell Lung Cancer (NSCLC)
    Schmid, S.
    Diem, S.
    Krapf, M.
    Li, Q.
    Flatz, L.
    Leschka, S.
    Desbiolles, L.
    Klingbiel, D.
    Jochum, W.
    Fruh, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2419 - S2420
12345